SG98409A1 - Pharmaceutical compositions and combinations for the treatment or prophylaxis of disorders related to hiv and retrovirus - Google Patents

Pharmaceutical compositions and combinations for the treatment or prophylaxis of disorders related to hiv and retrovirus

Info

Publication number
SG98409A1
SG98409A1 SG200003502A SG200003502A SG98409A1 SG 98409 A1 SG98409 A1 SG 98409A1 SG 200003502 A SG200003502 A SG 200003502A SG 200003502 A SG200003502 A SG 200003502A SG 98409 A1 SG98409 A1 SG 98409A1
Authority
SG
Singapore
Prior art keywords
retrovirus
prophylaxis
hiv
combinations
treatment
Prior art date
Application number
SG200003502A
Inventor
Chi-Chiang Yang
Original Assignee
Chi Chiang Yang
Hsiu Hsien Tsai
Shiou Ren Tsai
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chi Chiang Yang, Hsiu Hsien Tsai, Shiou Ren Tsai filed Critical Chi Chiang Yang
Priority to SG200003502A priority Critical patent/SG98409A1/en
Publication of SG98409A1 publication Critical patent/SG98409A1/en

Links

SG200003502A 2000-06-21 2000-06-21 Pharmaceutical compositions and combinations for the treatment or prophylaxis of disorders related to hiv and retrovirus SG98409A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SG200003502A SG98409A1 (en) 2000-06-21 2000-06-21 Pharmaceutical compositions and combinations for the treatment or prophylaxis of disorders related to hiv and retrovirus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG200003502A SG98409A1 (en) 2000-06-21 2000-06-21 Pharmaceutical compositions and combinations for the treatment or prophylaxis of disorders related to hiv and retrovirus

Publications (1)

Publication Number Publication Date
SG98409A1 true SG98409A1 (en) 2003-09-19

Family

ID=29997738

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200003502A SG98409A1 (en) 2000-06-21 2000-06-21 Pharmaceutical compositions and combinations for the treatment or prophylaxis of disorders related to hiv and retrovirus

Country Status (1)

Country Link
SG (1) SG98409A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0544321A1 (en) * 1991-11-27 1993-06-02 Kunio Konno Use of substituted cinnamic acid polymers to treat AIDS
US5346695A (en) * 1991-03-27 1994-09-13 Tampa Bay Research Institute Methods of inhibiting HIV replication in vitro using polymers of p-hydroxylated cinnamic acids
WO1995024899A1 (en) * 1994-03-14 1995-09-21 The Trustees Of Columbia University In The City Of New York Inhibition of cataracts and other disorders
WO1999066942A1 (en) * 1998-06-25 1999-12-29 Georgetown University Compounds obtained from salvia species having antiviral activity

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346695A (en) * 1991-03-27 1994-09-13 Tampa Bay Research Institute Methods of inhibiting HIV replication in vitro using polymers of p-hydroxylated cinnamic acids
EP0544321A1 (en) * 1991-11-27 1993-06-02 Kunio Konno Use of substituted cinnamic acid polymers to treat AIDS
WO1995024899A1 (en) * 1994-03-14 1995-09-21 The Trustees Of Columbia University In The City Of New York Inhibition of cataracts and other disorders
WO1999066942A1 (en) * 1998-06-25 1999-12-29 Georgetown University Compounds obtained from salvia species having antiviral activity

Similar Documents

Publication Publication Date Title
IL157734A0 (en) Pharmaceutical compositions for the treatment of urogenital disorders
AU2001278852A1 (en) Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
AU2001247331A1 (en) Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
HUP0100121A3 (en) Pharmaceutical compositions for the treatment of conditions responsive to testosterone elevation
HUP0401514A3 (en) Pharmaceutical compositions for the treatment of asthma
AU2002256359A1 (en) Antisense and anti-inflammatory based compositions to treat respiratory disorders
IL161052A (en) Immunogenic compositions for the prevention and treatment of meningococcal disease
HUP0200493A2 (en) Pharmaceutical compositions comprising sulphonyl-amino-carbonyl derivatives for the treatment of nuclear factor-kappa b mediated diseases
HU0103558D0 (en) Pharmaceutical composition for the treatment of stroke and traumatic brain insury
HUP0301167A3 (en) Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders, process for their preparation, pharmaceutical compositions containing them and their use
IL127943A (en) Pharmaceutical and cosmetic compositions for the treatment of skin disorders
NZ514044A (en) Herbal compositions and uses for the treatment of allergic reactions
HUP0400548A3 (en) Use of combinations of iop-reducing active inoredient for preparation of pharmaceutical compositions available for treatment glaucoma
HUP0401427A3 (en) Oral compositions for the treatment of scalp disorders
HK1082923A1 (en) Synergistic compositions for the prevention and treatment of acquired immunodeficiency
HUP0300402A3 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them
MXPA03007653A (en) Use of lp82 to treat hematopoietic disorders.
HUP0401633A3 (en) Use of irbesartan for the preparation of pharmaceutical compositions that are used to prevent or treat pulmonary hypertension
AU2002325169A1 (en) Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases
SG98409A1 (en) Pharmaceutical compositions and combinations for the treatment or prophylaxis of disorders related to hiv and retrovirus
IL160852A0 (en) Pharmaceutical compositions for the treatment of urinary disorders
HK1041444A1 (en) Pharmaceutical compositions comprising peg-asparaginase for the treatment of hiv infections
HUP0204258A3 (en) Use of vitamin d-derivatives for preparation of pharmaceutical compositions useful in the treatment of osteoporosis and related bone disorders, as well as novel vitamin d3-derivatives
HUP0002154A3 (en) Use of famotidine for the preparation of pharmaceutical compositions treating depression or symptoms related with depression
GB9602444D0 (en) Pharmaceutical compositions for the prevention or treatment of retrovirus infections